Company filings profile · CIK 0001589150
Regen BioPharma Inc — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Regen BioPharma Inc (RGBP): 3 filings in the last 90 days vs 2 in the prior 90 (filing-velocity rising ↑ · 1.5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Nov 4, 2026. Source-linked, daily-refreshed.
Material 8-K events — Regen BioPharma Inc
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Nov 2, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jul 15, 2026 | Entry into a Material Agreement; Change in Auditor; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 4, 2026 | Unregistered Sale of Securities | ↗ |
| Feb 2, 2026 | Unregistered Sale of Securities | ↗ |
| Jan 21, 2026 | Other Events | ↗ |
| Nov 13, 2025 | Unregistered Sale of Securities | ↗ |
| Oct 3, 2025 | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 19, 2025 | Unregistered Sale of Securities | ↗ |
| Aug 7, 2025 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 1, 2025 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jun 11, 2025 | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 13, 2025 | Non-Reliance on Prior Financials (restatement) | ↗ |
| Apr 7, 2025 | Change in Auditor | ↗ |
Watch Regen BioPharma Inc automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
| Filed | Form | |
|---|---|---|
| No insider filings in the current window. | ||
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Nov 2, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Aug 17, 2026 | 10-Q | 10-Q | ↗ |
| Aug 13, 2026 | NT 10-Q | NT 10-Q | ↗ |
| Jul 15, 2026 | 8-K | Entry into a Material Agreement; Change in Auditor; Other Events; Financial Statements and Exhibits | ↗ |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| Mar 4, 2026 | 8-K | Unregistered Sale of Securities | ↗ |
| Feb 13, 2026 | 10-Q | 10-Q | ↗ |
| Feb 2, 2026 | 8-K | Unregistered Sale of Securities | ↗ |
| Jan 21, 2026 | 8-K | Other Events | ↗ |
| Jan 12, 2026 | QUALIF | ↗ | |
| Jan 8, 2026 | 1-A POS | ↗ | |
| Dec 30, 2025 | 10-K | 10-K | ↗ |
| Dec 5, 2025 | 253G1 | 253G1 | ↗ |
| Dec 3, 2025 | QUALIF | ↗ | |
| Dec 1, 2025 | CORRESP | ↗ | |
| Nov 17, 2025 | 1-A | ↗ | |
| Nov 13, 2025 | 8-K | Unregistered Sale of Securities | ↗ |
| Oct 3, 2025 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 19, 2025 | 8-K | Unregistered Sale of Securities | ↗ |
| Sep 12, 2025 | SCHEDULE 13G | ↗ | |
| Sep 8, 2025 | 253G1 | 253G1 | ↗ |
| Sep 5, 2025 | QUALIF | ↗ | |
| Sep 4, 2025 | CORRESP | ↗ | |
| Sep 4, 2025 | UPLOAD | ↗ | |
| Aug 29, 2025 | 1-A | ↗ | |
| Aug 12, 2025 | 1-A-W | 1-A-W | ↗ |
| Aug 11, 2025 | 10-Q | 10-Q | ↗ |
| Aug 7, 2025 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Aug 1, 2025 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jun 11, 2025 | 8-K | Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 29, 2025 | 15-15D/A | 15-15D/A | ↗ |
| May 28, 2025 | 10-Q | 10-Q | ↗ |
| May 16, 2025 | 10-Q | 10-Q | ↗ |
| May 13, 2025 | 10-K | 10-K | ↗ |
| May 13, 2025 | 8-K | Non-Reliance on Prior Financials (restatement) | ↗ |
| Apr 7, 2025 | 8-K | Change in Auditor | ↗ |
| Mar 3, 2025 | 1-A POS | ↗ | |
| Feb 24, 2025 | 253G1 | ↗ | |
| Dec 31, 2024 | 15-15D/A | ↗ | |
| Dec 26, 2024 | 15-15D | ↗ |